Logiscreen

MoonLake Immunotherapeutics - Class A

$17.90
Market Cap 1.28B
ROE -86.4%
Gross Margin 0.0%
Debt/Equity 0.4
Current Ratio 8.6
Revenue QoQ 0.0%
EPS QoQ 0.6%
F-Score 1

About

Helix Acquisition Corp - Class A

Exchange
NASDAQ
Sector
Technology
Industry
Software - Application

Sector context

Technology

Undervalued

Trading at a discount to sector peers

P/E
-5.17
vs median 38.09
P/B
5.29
vs median 4.29
ROE
-0.86
vs median 0.18

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

PRGSCXMBLKBKAROPRCHAI
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics